Status:
COMPLETED
Caffeine in the Prevention of Post-operative Nausea and Vomiting
Lead Sponsor:
Beth Israel Deaconess Medical Center
Conditions:
Postoperative Nausea and Vomiting
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this study is to determine if caffeine 500 mg intravenously is efficacious when added to standard anti-emetic prophylaxis in the prevention of post-operative nausea and vomiting (PONV...
Detailed Description
This is a prospective, randomized, double-blind, placebo-controlled study of caffeine, 500 mg, intravenously, in addition to standard anti-emetic prophylaxis, in the prevention of post-operative nause...
Eligibility Criteria
Inclusion
- Patient having ambulatory surgery
- Patient receiving general anesthesia
Exclusion
- Patient is not willing to sign informed consent
- Patient does not speak or understand sufficient English
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2005
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT00130026
Start Date
March 1 2005
End Date
October 1 2005
Last Update
February 7 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215